Gregory Alan Korbel - Aug 25, 2021 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Chief Business Officer
Signature
/s/ Scott M. Coiante, attorney-in-fact
Stock symbol
APRE
Transactions as of
Aug 25, 2021
Transactions value $
-$4,573
Form type
4
Date filed
8/27/2021, 05:02 PM
Next filing
Sep 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Tax liability -$4.57K -1.15K -4.51% $3.98 24.4K Aug 25, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 3,333 restricted stock units.